◆ 会议时间:2020年8月24-26日
◆ 会议地点:澳大利亚 墨尔本
◆ 下届会议:2020年第21届亚太前列腺癌大会(APCC2020)
◆ 会议简介:
2019年20届亚太前列腺癌大会(APCC 2019)将于2019年8月24日至26日在澳大利亚墨尔本举行,会议由澳大利亚前列腺中心主办。届时,前列腺癌临床管理和研究领域的世界级领导者将齐聚一堂,分享他们丰富的知识和经验,讨论前列腺癌管理的各个方面,包括治疗和科学进展。本次会议将再次拥有一批优秀的国际师资队伍,为代表们提供一个有关前列腺癌研究和治疗的全球视角。APCC 2019 预计将吸引来自国内外的800余名代表参会。 ——未经本站许可,禁止复制转载摘录镜像本站任何内容-领域国际医学会议网。
邀请信:
The Australian Prostate Centre is proud to present the 20th Asia-Pacific Prostate Cancer Conference in Melbourne, Australia from the 24th to 26th of August 2019.
The Conference this year returns to the Melbourne Convention and Exhibition Centre and we are pleased to announce we will host the Conference in the new $205 million Goldfields development which was opened in July.
World leaders in prostate cancer clinical management and research will meet bringing their depth of knowledge and experience to discuss all facets of prostate cancer management including treatment and scientific advances. We are proud that the conference has grown over the last 20 years to be the world’s largest comprehensive meeting in the discipline.
Our aim is to view prostate cancer as a multi-disciplinary team effort and deliver a program that reflects this. The need for increased education, specialist training and sharing of knowledge in our quest for optimising prostate cancer outcomes has never been as important.
The Conference once again will have a stellar line up of International Faculty, providing delegates with a global perspective on Prostate Cancer research and treatment. The program will include streams of Clinical Urology, Translational Science, Nursing & Allied Health and General Practice. Our Committee are working on delivering a program which ensures the most contemporary information and research-validated findings are presented. We are witnessing treatment advances and new research findings at a rate never seen before.
We hope you can join us in celebrating our 20th Conference.
Yours Sincerely,
PROF ANTHONY COSTELLO AM
President of the 20th Asia-Pacific Prostate Cancer Conference 2019
APCC 2019 注册费:
|
EARLY REGISTRATION
Prior to 7 July |
GENERAL REGISTRATION
From 7 July to 24 August |
ON-SITE REGISTRATION
From 24 August |
Full Registration Fees |
Urologist, Radiation Oncologist or Medical Oncologist |
$1,050.00 |
$1,290.00 |
$1,500.00 |
Trainee, Registrar or Fellow |
$950.00 |
$1,100.00 |
$1,400.00 |
Developing Country |
$950.00 |
$1,100.00 |
$1,400.00 |
Nursing & Allied Health |
$750.00 |
$875.00 |
$975.00 |
Scientist or Researcher |
$560.00 |
$775.00 |
$975.00 |
Student Post Doc (Evidence Required) |
$500.00 |
$675.00 |
$875.00 |
Day Registration Fees |
Urologist, Radiation Oncologist or Medical Oncologist |
$700.00 |
$750.00 |
$750.00 |
Trainee, Registrar or Fellow |
$490.00 |
$540.00 |
$540.00 |
Developing Country |
$500.00 |
$595.00 |
$595.00 |
Nursing & Allied Health |
$500.00 |
$550.00 |
$550.00 |
Scientist or Researcher |
$400.00 |
$495.00 |
$495.00 |
Student Post Doc (Evidence Required) |
$350.00 |
$445.00 |
$445.00 |
General Practitioners Prostate Cancer Workshop – Saturday 24 August |
General Practice Only |
Complimentary |
Complimentary |
Complimentary |
Conference Workshops |
Friday 23 August |
|
|
|
New Frontiers in Robotic Surgery |
$850.00 |
$950.00 |
$995.00 |
Saturday 24 August |
|
|
|
MRI & Prostate Cancer Diagnosis |
Complimentary to full registrations and Saturday Day Delegates |
Non Delegates |
$350.00 |
$400.00 |
$500.00 |
Knowing the literature: An overview of the most important papers in prostate cancer from a multidisciplinary panel |
Complimentary to full registrations and Saturday Day Delegates |
Radiation Oncology |
Complimentary to full registrations and Saturday Day Delegates |
Non Delegates |
$350.00 |
$400.00 |
$500.00 |
Sexual Dysfunction – The Patient and the Partner |
Complimentary to full registrations and Saturday Day Delegates |
All registration prices are in Australian Dollars and inclusive of Australian Goods and Services Tax (GST)
Industry registrations – Please note you must be a participating sponsor or exhibitor to attend the Conference.
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|